购物车
- 全部删除
- 您的购物车当前为空
Oditrasertib (DNL-788) 是一种高效的 RIPKl 抑制剂,其 IC50 值低于 100 nM。Oditrasertib 可用于研究多发性硬化症和阿尔茨海默症等免疫系统疾病与神经系统疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
Oditrasertib (DNL-788) 是一种高效的 RIPKl 抑制剂,其 IC50 值低于 100 nM。Oditrasertib 可用于研究多发性硬化症和阿尔茨海默症等免疫系统疾病与神经系统疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,650 | 现货 | |
5 mg | ¥ 3,480 | 现货 | |
10 mg | ¥ 4,960 | 现货 | |
25 mg | ¥ 7,560 | 现货 | |
50 mg | ¥ 9,870 | 现货 | |
100 mg | ¥ 13,700 | 现货 | |
200 mg | ¥ 18,500 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,180 | 现货 |
产品描述 | Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.Oditrasertib can be used for the study of immune and neurological disorders such as multiple sclerosis and Alzheimer's disease. |
别名 | DNL-788 |
分子量 | 295.28 |
分子式 | C14H15F2N3O2 |
CAS No. | 2252271-93-3 |
Smiles | N#CC1=CN=CC2=C1OCCN(C(=O)C(C)(C)C(F)F)C2 |
存储 | keep away from direct sunlight,store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (270.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容